Background: Selective recognition and binding of IgG molecules is the basis for a host of immunological and affinity purification techniques. Capture of an IgG in these procedures relies chiefly on its interaction with one of a variety of reengineered bacterial receptors which bind to the Fc region of IgG molecules with very high affinity. While this interaction is extremely efficient in trapping IgG molecules, the tight interaction between the binding partners often requires denaturing conditions for disruption of the complex, which can adversely affect the yield of purified IgG and also limit the lifetime of the receptor matrix. An effective receptor/ IgG binding system which could be modulated by less extreme conditions is of considerable general interest.
Introduction
A variety of commonly employed biochemical and molecular biological procedures rely on the recognition of binding targets by speci¢c antibody molecules, particularly class G immunoglobulins (IgG) [1] . Puri¢cation of IgG molecules is typically achieved via a¤nity separation by binding to one of a number of bacterially derived IgG receptor proteins [2] . The most common of these receptors are protein A from Staphylococcus aureas, protein G from group G Streptococcus and protein L from Peptostreptococcus magnus. Each of these cell wall proteins comprises several small extracellular domains that bind the Fc regions of IgG molecules with high a¤nity [3^6] . Engineered derivatives of these proteins retaining one or more of the IgG binding domains have been used to construct agaroseor sepharose-based a¤nity matrices for puri¢cation purposes [7^10] . Although these reagents are speci¢c for IgG from numerous species (with varying species selectivity depending on the receptor used) [11] and therefore e¡ect very clean separations, the necessary dissociation of the IgG^receptor complex is di¤cult to achieve because of the high a¤nity of the interaction. As a result, denaturation of the complexes^typically by extreme pH changesî s the most commonly used method for releasing the matrix-bound IgG targets. While these harsh treatments are e¡ective for disrupting the complexes, the recovery of correctly folded, and therefore active, IgG may vary [12^14] . Any procedure employing a more gentle method of IgG receptor release is therefore of considerable general interest.
Here we describe a series of modi¢ed Fc receptors based on the B1 IgG binding domain from protein G that can be reversibly unfolded by addition of transition metal ion salts. In the absence of metal ions, these domains are fully folded and retain the ability to bind IgG molecules with high a¤nity. However, addition of metal ions results in disruption of the folded structure of the domains su¤cient to eliminate IgG binding. This e¡ect is fully reversible : upon removal of metal ions by chelators such as EDTA, the domains refold and are once again competent to bind IgG. We present data illustrating the e¡ect of metal ions on the structure and binding functions of a series of these domains^responsive over a range of metal ion concentrations^and suggest potential applications of these domains in IgG binding procedures, a¤nity separations of IgG molecules and receptor fusion constructs.
Results and discussion

Domain construction and disruption of secondary structure by metal
The Fc receptors reported here are all derivatives of two designed metal binding variants of the B1 domain of protein G (Fig. 1) . These proteins, which bind metal with high a¤nity, each incorporate a designed metal binding site positioned at the interface of the domain's single K-helix and second L-strand. By contrast, the high a¤nity Fc binding site is located on the opposite side of the domain, and incorporates residues from the helix and third Lstrand with no overlap with the metal site region. The site is comprised of three histidine residues at positions 16, 18 and 30 and a cysteine residue at position 33 [15] . The two metal binding B1 variants are di¡erentiated by an additional mutation in one of them^a residue 5 substitution of methionine for the wild-type leucine^and are referred to as ZL1M and ZL1L re£ecting this residue 5 di¡erence. Both of these domains are folded and stabilized toward thermal denaturation in the presence of metal. Several variant domains have been constructed, in both the ZL1M and ZL1L backgrounds, in which the metal site Cys33 residue is substituted with a series of non-chelating amino acids. The mutants are named based on the individual Cys33 substitution and the background in which it was made, i.e.`LMet' denotes ZL1L with a methionine substituted for cysteine,`MVal' denotes ZL1M with valine substituted for cysteine. In all cases the substitution results in folded IgG binding domains in the absence of metal which, upon metal addition, display dramatic changes in secondary structure content.
Metal titration experiments of all of the domains show a progressive loss of secondary structure with increasing Zn(II) concentration as demonstrated by the loss of intensity in the respective circular dichroism (CD) spectra ( Fig.  2A and B) . The amount of metal required to achieve the maximum change is higher for the ZL1L-based variants, but varies within that set for the di¡erent substitutions of Cys33, likely re£ecting di¡ering a¤nities for metal for each of the variants. Similar titrations followed by [ 1 H]NMR show well dispersed spectra for the apo proteins, similar to those of the wild-type B1 domain, which progressively broaden upon addition of increasing amounts of Zn(II) (Fig. 2C) . Both of these experiments are consistent with a major alteration in the folded structure of the variants upon their interaction with metal. These metal-induced structural changes were also indicated in experiments with the £uorescent dye 8-anilino-1-naphthalene sulfonic acid (ANS). ANS is commonly used to follow changes in exposed hydrophobic surface area upon disruption of a protein's native structure [16, 17] . Addition of ANS to the Fc receptor variants showed both intensity increases and V max shifts in the £uorescence emission spectrum of the dye upon addition of Zn(II) (Fig.  2D ). As Zn(II) alone had no e¡ect on ANS £uorescence, these results are consistent with the metal-induced perturbations indicated by the CD and NMR titration spectra. Together these experiments indicate that association with metal results in at least a partial unfolding of all of the Cys33 substitution variants.
Metal binding disrupts IgG binding
The e¡ects of the metal-induced unfolding of the Fc receptor variants on their IgG binding properties were assessed in two di¡erent IgG binding assays. The ¢rst employed a competition assay for binding to IgG immobilized on microtiter plates. Each of the variant proteins was titrated against a ¢xed amount of wild-type protein G conjugated with alkaline phosphatase (G/AP) (Fig. 3A) . Conjugate cleavage of the chromogenic alkaline phosphatase substrate p-nitrophenyl phosphate (PNPP) resulted in an increase in absorbance at 405 nm proportional to the amount of G/AP remaining after equilibration and washing of the IgG-coated wells. Thus, variants which were competent to bind IgG and, therefore, capable of competing away the G/AP conjugate, caused a decrease in A 405 with increasing concentration. As shown in Fig. 3B , in the absence of metal all of the variants displayed an ability to e¡ectively compete with the G/AP conjugate that was nearly identical to that of the unmodi¢ed B1 domain. Addition of Zn(II) to the equilibration mixtures when the concentrations of both G/AP and Fc receptor variants were held constant resulted in a corresponding increase in A 405 with increasing amounts of added metal, indicating that the presence of Zn(II) disrupts the ability of the variants to e¡ectively bind the target IgG (Fig. 3C ). No e¡ect of metal was seen on the ability of the unmodi¢ed B1 domain to compete for IgG binding. These data demonstrate that, while the domains retain nearly wild-type IgG binding activity, the presence of metal disrupts their folded structure and renders them unable to recognize and bind their targets.
The second assay was performed to further investigate the e¡ect of metal binding on IgG binding, speci¢cally, whether metal would have the same e¡ect on the structure and binding of the modi¢ed Fc receptor domains if added to a pre-formed IgG/Fc receptor complex. For this experiment, a new variant was constructed incorporating a Gly-Ser-Gly-Cys linker at the C-terminus of one of the Fc receptor variants, LIle. The resulting protein, LIleC, was then quantitatively immobilized via disul¢de linkage to a thiol-agarose resin (Fig. 4A) . After addition and binding of whole human IgG to the column, the resin was washed and IgG eluted by addition of 100 mM CdCl 2 (Fig. 4B ). Subsequent addition of EDTA to strip metal from the column resulted in refolding of the domains, allowing the resin to be used again for productive IgG binding (not shown). Repeated cycles of metal binding and EDTA stripping could be visualized in the absence of IgG by adding Co(II) to the column and monitoring the color change of only the portion of the resin that had been saturated with Fc receptor (not shown). Control experiments using underivatized thiolagarose resin showed no retention/metal elution of IgG (Fig. 4B) . These results indicate that the e¡ect of metal on the Fc variants is a disruption of the native structure that results both in the prevention of IgG binding and in the disruption of pre-formed IgG/Fc receptor complexes.
Applications
We envision utilizing these domains, alone or in combination, as alternatives to the Fc receptors currently in use. Our domains, while retaining their high a¤nity IgG binding functions in the absence of metal ions, can be gently and reversibly unfolded without the need to denature their target IgG molecules required for the currently used systems. If necessary, removal of residual metal ions and/or chelator^metal complexes from the ¢nal sample is easily achieved via a gel ¢ltration step subsequent to the unfolding of the domains and elution of the desired product. The reversibility of the unfolding reaction will likely result in a¤nity reagents with longer useful lifetimes than those which must be completely denatured for IgG release. This reversibility also makes possible the in situ activation/deactivation of the binding functions of these domains simply by adding transition metal ions or chelators to the bu¡er. These domains can be used in any application where immobilization and/or capture of intact, active IgG is desired.
The behavior of the domains in the ANS experiments also illustrates their potential utility as metal ion biosensors. The coupling of the binding event to an easily monitored signal, combined with the di¡ering metal a¤nities exhibited by this series of variants, makes possible the construction of sensor arrays for detecting the presence of metal ions across a range of concentrations [18^21]. It may also be possible to design constructs with intrinsic reporter groups, to eliminate the need for external additions.
We also anticipate the utility of these domains as general a¤nity reagents to be used as protein expression tools. The successful overexpression of recalcitrant proteins by fusion to e¤ciently expressed partners has been repeatedly demonstrated [22^26] . The domains reported here all can be expressed in Escherichia coli at up to 20 mg/l of cell culture. Fusion proteins prepared with these domains could be overexpressed and then easily puri¢ed by passage over an IgG a¤nity matrix [27] , after which the complex may be released by adding metal ions to the bu¡er, or the fusion cleaved by means of a protease cleavage signal engineered into the linker connecting the two proteins (Fig.  5) . We believe that the combination of inexpensive, gentle, reversible unfolding conditions and ease of production will make these domains useful tools in many di¡erent applications.
Signi¢cance
Receptor-mediated recognition and capture of IgG molecules are important steps in many immunological protocols, both for immobilization/puri¢cation of the antibodies themselves and for a¤nity puri¢cation of desired antigens. Because the harsh conditions generally required for disruption of the receptor/IgG complex can adversely a¡ect product yield, systems employing milder elution methods have broad application. We describe a series of modi¢ed Fc receptors that are competent to form high a¤nity complexes with IgG molecules that are reversibly disrupted upon addition of transition metal ions. The binding of metal ions results in a dramatic change in the folded structure of the domains which is su¤cient to prevent IgG binding and disrupt pre-formed receptor/IgG complexes. Removal of the metal ions results in the complete refolding of the domains, thus allowing the same domains to be used for repeated IgG binding steps. The range of metal sensitivities demonstrated for the receptor variants and their potential for use also in non-immunological procedures, de¢ne a £exible and versatile system amenable to a variety of applications.
Materials and methods
Construction of B1 variants
All ZL1 variants were cloned according to standard protocols [28] into the vector pET11av. pET11av is a T7 expression vector and is identical to the pET11a vector except that it lacks a HindIII restriction enzyme site [29] . The genes for the Cys33 substitution mutants were constructed by PCR using the pZL1M vector as template. The oligonucleotide SM6 (GCTACCGCGGAAAA-AGTTCACAAACAG[(AGT)T(CG)]GCTAA CGACAACG) was used as the forward primer in a PCR reaction with primer Asp4 (GCTCAGCGGTGGCAGCAGCCAAC) to introduce the Cys33 mutations. SM6 was synthesized with the degenerate sequence (AGT)T(CG) for codon 33 in order to produce a pool of primers containing six possible codons at this position, coding for the amino acids Ile, Leu, Met, Phe and Val [30] . The PCR products were then digested with SalI and BamHI and ligated into both pZL1M and pZL1L. All variants were expressed and puri¢ed as described previously [15] .
Circular dichroism
Circular dichroism spectra were recorded on an Aviv 62DS instrument in 2 mm pathlength quartz cuvettes and were all acquired at 4³C. All protein samples were prepared by passage over a PD-10 column (Pharmacia) into 1 mM MOPS, pH 6.8, and diluted to approximately 20 WM. All sample concentrations were veri¢ed by A 280 before and after scans of metal titration samples. Scan data were plotted as MRE (mean residue ellipticity) according to:
where a is the observed ellipticity, [P] is the sample protein concentration (M), 0.2 is the cell pathlength (cm) and 0.01 is a unit conversion factor.
ANS £uorescence assays
Fluorescence measurements for ANS binding were obtained on an SLM 8100 spectro£uorometer at 4³C. Experiments were performed in a 1 cm quartz cuvette using 20 WM protein in 1 mM MOPS, pH 6.8 in a total volume of 900 Wl. Spectra were recorded using an excitation wavelength of 374 nm and were taken with protein alone, after addition of 200 WM ANS and after addition of a speci¢ed amount of Zn(II) (as ZnCl 2 ). All spectra were corrected for dilution and baseline o¡set. 
Structure assessment by one-dimensional (1D) 1 H NMR
Protein samples prepared for NMR experiments were desalted into 20 mM Tris bu¡er, pH 6.9 and concentrated to approximately 2.5 mM by centrifugation in Centricon concentrators with a 3 kDa molecular weight cuto¡ (Amicon). Metal titrations were conducted by direct addition of ZnSO 4 in Tris bu¡er to the sample in the NMR tube, and were mixed by inversion. All NMR samples contained 10% D 2 O as an internal standard and were collected using a Varian Unity 500 MHz magnet at 15³C and processed with the program Felix (Biosym).
IgG binding assays
Assessment of the IgG binding ability of each of the ZL1 variants was performed by using a competition assay with a wildtype protein G/alkaline phosphatase conjugate (G/AP). The bottoms of wells of high protein binding 96-well microtiter plates (Immunosorp, Nunc) were coated with whole human IgG by addition of 50 Wl of a 30 Wg/ml solution in coating bu¡er (CB; 50 mM HEPES, 150 mM NaCl, 0.02% NaN 3 , pH 7.2) and incubation at room temperature for 2 h. Care was taken to contact only the bottoms of the wells with IgG solution, in order to ensure reproducibility of signal from each set of wells. After incubation, the IgG solution was carefully removed via pipette and the wells were washed two times with 300 Wl each of CB; the ¢rst wash was allowed to stand for 1 min before CB removal and subsequent wash. Coated, washed wells were then blocked by addition of 300 Wl CB with either 10% FCS or 3% BSA added and allowed to stand overnight at 4³C. For IgG binding competition experiments, all components were added in a solution of CB with either 5% FCS or 1.5% BSA and 5 mM TCEP. A constant amount of G/AP (6.0 Wg/ml) was added to each mixture, along with increasing amounts of competitor ZL1 protein (between 0 and 0.6 or 1.2 mM). The`wild-type' B1 domain used has the substitution T2Q to circumvent incomplete processing of the N-terminal methionine [15] , and in all other respects behaves as the original B1 domain from Streptococcus (the ZL1 mutants also contain the T2Q substitution). For experiments with metal present, the same G/AP concentration was used with 0.3 mM competitor protein (determined to be a saturating amount of competitor in all assays) in the same CB/block/TCEP bu¡er but with increasing amounts of added ZnSO 4 (between 0 and 1.3 mM). Final volume in all wells was 50 Wl. Solutions were added to coated/blocked plates after washing the wells two times with CB with 5% FCS or 1.5% BSA. Mixtures were incubated at room temperature for 24^48 h before developing. Plates were developed by careful removal of the binding mixtures followed by washing four times with CB. Wells were then washed two times with diethanolamine substrate bu¡er (10 mM diethanolamine, 0.5 mM MgCl 2 , pH 9.5) and 50 Wl of a 1 mg/ml solution of PNPP was added in the same bu¡er to initiate the developing reaction. The reactions were allowed to proceed for 15^30 min at room temperature before being quenched by the addition of 50 Wl of 0.1 M EDTA followed by reading of A 405 in a microplate reader. All reactions were performed in duplicate or triplicate and averaged. Deviations between A 405 of identical wells were generally between 5 and 10% of the total absorbance.
Construction of ZL1 variant IgG a¤nity resin
The ZL1LileC variant was immobilized on a solid support to create an IgG a¤nity matrix. The oligonucleotide primer LIleCC was used in a PCR reaction to produce a modi¢ed LIle gene which resulted in the addition of a Gly-Ser-Gly-Cys tetrapeptide sequence to the C-terminus of the LIle protein. The resulting mutant was expressed and puri¢ed as described previously for the ZL1 proteins. For column immobilization, pure LIleC protein was incubated with a 50-fold molar excess of DTT at room temperature for 20 min. DTT was removed from the reduced protein by passage over a PD-10 column into bu¡er containing 100 mM MOPS, 1 mM EDTA, pH 6.8. The resulting sample (typically between 1.2 and 1.6 Wmol) was then applied to a column containing 2 ml of TNB-thiol agarose (Pierce), preequilibrated in the MOPS/EDTA bu¡er. The binding capacity of the TNB-thiol resin was approximately 5 Wmol/ml. Binding of the LIleC mutant was quanti¢ed by measuring the concentration of TNB eluted during the binding and wash steps and generally exceeded 90% of the total loaded. The column was washed with MOPS/EDTA until the TNB absorbance at A 410 reached baseline. Between 0.8 and 0.11 Wmol of whole human IgG in MOPS/EDTA was then added to the column and the resin was washed with bu¡er until A 280 reached baseline. IgG binding to the column was typically 50^60% of the total loaded. Bound IgG was eluted from the column by addition of 100 mM MOPS, 100 mM CdCl 2 , pH 6.8, with washing until A 280 reached baseline. Bound and eluted IgG was assessed by A 280 and on 18% reducing, sodium dodecyl sulfate (SDS)^polyacrylamide gels, to con¢rm which species were present in the eluates.
